Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Male breast cancer is not congruent with the female disease.

Fentiman IS.

Crit Rev Oncol Hematol. 2016 May;101:119-24. doi: 10.1016/j.critrevonc.2016.02.017. Epub 2016 Feb 27. Review.

PMID:
26989051
2.

Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer.

Eggemann H, Altmann U, Costa SD, Ignatov A.

J Cancer Res Clin Oncol. 2018 Feb;144(2):337-341. doi: 10.1007/s00432-017-2539-7. Epub 2017 Nov 2.

PMID:
29098396
3.

Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay.

Curigliano G, Colleoni M, Renne G, Mazzarol G, Gennari R, Peruzzotti G, de Braud E, Robertson C, Maiorano E, Veronesi P, Nolè F, Mandalà M, Ferretti G, Viale G, Goldhirsch A.

Ann Oncol. 2002 Jun;13(6):895-902.

PMID:
12123335
4.

Male breast cancer in the veterans affairs population: a comparative analysis.

Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R.

Cancer. 2007 Apr 15;109(8):1471-7.

5.

Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.

Biesma HD, Schouten PC, Lacle MM, Sanders J, Brugman W, Kerkhoven R, Mandjes I, van der Groep P, van Diest PJ, Linn SC.

Genes Chromosomes Cancer. 2015 Dec;54(12):734-44. doi: 10.1002/gcc.22284. Epub 2015 Sep 10.

PMID:
26355282
6.

Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.

Takagi K, Moriya T, Kurosumi M, Oka K, Miki Y, Ebata A, Toshima T, Tsunekawa S, Takei H, Hirakawa H, Ishida T, Hayashi S, Kurebayashi J, Sasano H, Suzuki T.

Horm Cancer. 2013 Feb;4(1):1-11. doi: 10.1007/s12672-012-0126-6. Epub 2012 Oct 18.

PMID:
23096432
7.

High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer.

Johansson I, Nilsson C, Berglund P, Strand C, Jönsson G, Staaf J, Ringnér M, Nevanlinna H, Barkardottir RB, Borg A, Olsson H, Luts L, Fjällskog ML, Hedenfalk I.

Breast Cancer Res Treat. 2011 Oct;129(3):747-60. doi: 10.1007/s10549-010-1262-8. Epub 2010 Nov 27.

PMID:
21113657
8.

Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.

Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S, Gariboldi M, Pierotti MA, Daidone MG.

Breast Cancer Res Treat. 2011 Jun;127(3):601-10. doi: 10.1007/s10549-010-1015-8. Epub 2010 Jul 13.

PMID:
20625818
9.

A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).

Yu XF, Yang HJ, Yu Y, Zou DH, Miao LL.

PLoS One. 2015 Aug 27;10(8):e0136670. doi: 10.1371/journal.pone.0136670. eCollection 2015.

10.

Men and women show similar survival outcome in stage IV breast cancer.

Wu SG, Zhang WW, Liao XL, Sun JY, Li FY, Su JJ, He ZY.

Breast. 2017 Aug;34:115-121. doi: 10.1016/j.breast.2017.05.012. Epub 2017 May 31.

PMID:
28577471
11.

Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden).

Nilsson C, Holmqvist M, Bergkvist L, Hedenfalk I, Lambe M, Fjällskog ML.

Acta Oncol. 2011 Oct;50(7):1083-8. doi: 10.3109/0284186X.2011.602114. Epub 2011 Aug 11.

PMID:
21830994
12.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
13.

Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.

Ottini L, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, Masala G, Navazio AS, Capalbo C, Bianchi S, Manoukian S, Barile M, Peterlongo P, Caligo MA, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Cini G, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2014 Dec;148(3):623-8. doi: 10.1007/s10549-014-3193-2. Epub 2014 Nov 11.

PMID:
25385181
14.

Tracing differences between male and female breast cancer: both diseases own a different biology.

Kornegoor R, van Diest PJ, Buerger H, Korsching E.

Histopathology. 2015 Dec;67(6):888-97. doi: 10.1111/his.12727. Epub 2015 Jun 26.

PMID:
25941088
15.

Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.

Johansson I, Lauss M, Holm K, Staaf J, Nilsson C, Fjällskog ML, Ringnér M, Hedenfalk I.

Mol Oncol. 2015 Oct;9(8):1565-79. doi: 10.1016/j.molonc.2015.04.013. Epub 2015 May 8.

17.

Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.

Johansson I, Nilsson C, Berglund P, Lauss M, Ringnér M, Olsson H, Luts L, Sim E, Thorstensson S, Fjällskog ML, Hedenfalk I.

Breast Cancer Res. 2012 Feb 14;14(1):R31.

18.

Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.

Fields EC, DeWitt P, Fisher CM, Rabinovitch R.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):747-52. doi: 10.1016/j.ijrobp.2013.07.016.

PMID:
24138917
19.

The biology of male breast cancer.

Fentiman IS.

Breast. 2018 Apr;38:132-135. doi: 10.1016/j.breast.2018.01.001. Epub 2018 Jan 6. Review.

PMID:
29316513
20.

Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.

André S, Pinto AE, Laranjeira C, Quaresma M, Soares J.

Pathobiology. 2007;74(6):323-7. Epub 2007 Dec 13.

Supplemental Content

Support Center